CCL5 knockdown diminished the expression of lymphangiogenesis marker LYVE-1 and VEGF-C in vivo. CCL5 serves as a potent positive-regulator of tumor lymphangiogenesis in human chondrosarcoma. Here, CCL5 is linked to neoplasm.